MARIELA SANDI: Open Payments
NPI 1407227556 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,120 in 41 payments from 16 companies in 2025. Trend: 2023 $1,222 · 2024 $490 · 2025 $1,120
Food & beverage: $1,120
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 9 | $229 |
| Kerecis Limited | 2 | $137 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $137 |
| Janssen Biotech, Inc. | 3 | $89 |
| UROGEN PHARMA, INC. | 2 | $70 |
| Endo USA, Inc. | 4 | $62 |
| ABBVIE INC. | 2 | $60 |
| Becton, Dickinson and Company | 1 | $58 |
| Medtronic, Inc. | 2 | $51 |
| Myriad Genetic Laboratories, Inc. | 2 | $49 |
Products named: GEMTESA, Kerecis SurgiClose, Nubeqa, ERLEADA, BOTOX, Bard Urinary Drainage Bag, INTERSTIM, XYOSTED.
Industry payments across LA — which companies pay providers there.
